1 |
soluble HLA class I
(24 times)
|
Allergy and Immunology (12 times)
|
sFasL (4 times) CTL (3 times) HLA (3 times)
|
1996 Influence of anticoagulants on the level of soluble HLA class I and class II antigens measured in blood samples.
|
2 |
soluble HLA class I antigens
(11 times)
|
Allergy and Immunology (3 times)
|
AHG (1 time) beta 2-mu (1 time) beta2m (1 time)
|
1995 Serum soluble HLA class I antigen levels in hemodialysis patients and following renal transplantation.
|
3 |
soluble human leukocyte antigens class I
(9 times)
|
Allergy and Immunology (3 times)
|
ELISA (2 times) CMV (1 time) COPD (1 time)
|
2001 Clinical significance of soluble form of HLA class I molecule in Japanese patients with pancreatic cancer.
|
4 |
soluble HLA-I
(7 times)
|
Allergy and Immunology (2 times)
|
beta2m (1 time) CLIR (1 time) CSF (1 time)
|
1998 Increased circulating levels of soluble HLA class I heterodimers in patients with sickle cell disease.
|
5 |
sHLA class I
(2 times)
|
Hematology (1 time)
|
sHLA (2 times) AU (1 time) FHC (1 time)
|
2000 Therapeutic immunoadsorption increases the level of circulating soluble HLA molecules.
|
6 |
soluble counterparts of HLA Class I
(2 times)
|
Allergy and Immunology (2 times)
|
dsHLA (1 time) dsHLA-I (1 time) EMB (1 time)
|
1999 Anti-HLA antibodies interfere in the detection of soluble HLA class I molecules.
|
7 |
soluble human leukocyte class I antigens
(2 times)
|
Toxicology (1 time)
|
HCV (1 time) IFN-alpha (1 time) NK (1 time)
|
1998 Serum concentrations of soluble human leukocyte class I antigens and of the soluble intercellular adhesion molecule-1 in endometriosis: relationship with stage and non-pigmented peritoneal lesions.
|
8 |
soluble beta2-mu-associated HLA Class I heavy chains
(1 time)
|
Allergy and Immunology (1 time)
|
sHLA-FHC (1 time) SLE (1 time)
|
1998 Increased level of serum HLA class I antigens in patients with systemic lupus in patients with systemic lupus erythematosus. Correlation with disease activity.
|
9 |
soluble class I HLA molecules
(1 time)
|
Allergy and Immunology (1 time)
|
---
|
2014 Soluble HLA-I/peptide monomers mediate antigen-specific CD8 T cell activation through passive peptide exchange with cell-bound HLA-I molecules.
|
10 |
soluble Class I human leukocyte antigens
(1 time)
|
Hematology (1 time)
|
LAK (1 time) NK (1 time) RBC (1 time)
|
2011 Down regulation of human natural killer cell-mediated cytolysis induced by blood transfusion: role of transforming growth factor-beta(1), soluble Fas ligand, and soluble Class I human leukocyte antigen.
|
11 |
Soluble form of HLA antigens
(1 time)
|
Otolaryngology (1 time)
|
SNHL (1 time)
|
2002 [Immuno-genetic significance in sensorineural hearing loss (SNHL) in the light of our own investigations].
|
12 |
soluble HLA class I surface antigen
(1 time)
|
Science (1 time)
|
IFNbeta-1a (1 time) RRMS (1 time)
|
2005 Soluble HLA class I and class II molecules in relapsing-remitting multiple sclerosis: acute response to interferon-beta1a treatment and their use as markers of disease activity.
|
13 |
soluble HLA-A, B and C class Ia
(1 time)
|
Neurology (1 time)
|
CSF (1 time) ELISA (1 time) MRI (1 time)
|
2006 Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.
|
14 |
soluble human leukocyte antigen class I molecules
(1 time)
|
Allergy and Immunology (1 time)
|
ICTP (1 time) RANKL (1 time)
|
2008 The clinical significance of soluble human leukocyte antigen class-I, ICTP, and RANKL molecules in multiple myeloma patients.
|
15 |
soluble human MHC class I
(1 time)
|
Allergy and Immunology (1 time)
|
---
|
2000 Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes.
|
16 |
Soluble molecules of HLA-I
(1 time)
|
Allergy and Immunology (1 time)
|
CsA (1 time) IRS (1 time) NCR (1 time)
|
2005 Cyclosporin A regulates human NK cell apoptosis induced by soluble HLA-I or by target cells.
|
17 |
such as HLA-I
(1 time)
|
Allergy and Immunology (1 time)
|
---
|
2006 Mechanisms of tumor escape: role of tumor microenvironment in inducing apoptosis of cytolytic effector cells.
|